Gladstone Institutional Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Buy |
+418
| New | +$219K | 0.01% | 690 |
|
|
2023
Q4 | – | Sell |
-873
| Closed | -$718K | – | 696 |
|
|
2023
Q3 | $718K | Sell |
873
-4
| -0.5% | -$3.29K | 0.05% | 323 |
|
|
2023
Q2 | $630K | Buy |
+877
| New | +$630K | 0.04% | 359 |
|
|
2022
Q3 | – | Sell |
-980
| Closed | -$579K | – | 674 |
|
|
2022
Q2 | $579K | Buy |
+980
| New | +$579K | 0.05% | 381 |
|
|
2021
Q4 | – | Sell |
-1,471
| Closed | -$890K | – | 626 |
|
|
2021
Q3 | $890K | Buy |
+1,471
| New | +$890K | 0.09% | 240 |
|
|
2020
Q4 | – | Sell |
-530
| Closed | -$297K | – | 317 |
|
|
2020
Q3 | $297K | Sell |
530
-208
| -28% | -$117K | 0.07% | 209 |
|
|
2020
Q2 | $460K | Buy |
+738
| New | +$460K | 0.12% | 137 |
|